Table II.
Item | Factor |
Domain | |||
---|---|---|---|---|---|
1 | 2 | 3 | 4 | ||
Q2 | 0.722 | Administration of autoinjectors | |||
Q3 | 0.612 | 0.313 | Administration of autoinjectors | ||
Q7 | 0.797 | Administration of autoinjectors | |||
Q16 | 0.750 | Administration of autoinjectors | |||
Q17 | 0.660 | Administration of autoinjectors | |||
Q19 | 0.355 | −0.314 | Administration of autoinjectors | ||
Q5 | 0.636 | Avoiding exposure | |||
Q11 | 0.481 | Avoiding exposure | |||
Q13 | 0.452 | −0.378 | Avoiding exposure | ||
Q15 | 0.635 | Avoiding exposure | |||
Q4 | 0.369 | −0.497 | Anaphylaxis and symptoms | ||
Q6 | 0.417 | Anaphylaxis and symptoms | |||
Q9 | 0.603 | Anaphylaxis and symptoms | |||
Q10 | 0.506 | Anaphylaxis and symptoms | |||
Q12 | 0.588 | Anaphylaxis and symptoms | |||
Q14 | 0.303 | 0.502 | Anaphylaxis and symptoms | ||
Q1 | 0.510 | Basic FA knowledge | |||
Q8 | 0.594 | Basic FA knowledge | |||
Q18 | 0.305 | Basic FA knowledge | |||
Q20 | 0.328 | Basic FA knowledge |